Loading clinical trials...

Remote Monitoring and Virtual Collaborative Care For Hypertension Control To Prevent Cognitive Decline | Clinical Trials | Clareo Health

COMPLETEDNA

Remote Monitoring and Virtual Collaborative Care For Hypertension Control To Prevent Cognitive Decline

Remote Monitoring and Virtual Collaborative Care For Hypertension Control To Prevent Cognitive Decline: Phase I

NCT04585880•University of Kansas Medical Center

View on ClinicalTrials.gov

Summary

This purpose of this study is to examine an aggressive method of blood pressure control that involves home blood pressure monitoring and management of medications by a team of clinical pharmacists in coordination with a primary care physician.

Eligibility

Age

65 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age 65 and older
•Active patient in participating primary care clinic
•Access to compatible "smartphone" or device (i.e., Android, Kindle or Apple with internet connectivity)
•Elevated blood pressure as defined by:
•Systolic Blood Pressure \>140 at current visit AND documented history of hypertension OR Systolic Blood Pressure \> 140 at current visit and at another visit in last 18 months OR Systolic Blood Pressure \>160 at current visit
•Sufficiently fluent in English to participate in study procedures
•Adequate vision and hearing to complete study procedures

Exclusion Criteria

•Clinically significant illness that may affect safety or completion per their treating Primary Care Physician or study physician
•End stage renal disease on dialysis
•Chronic active disease with expected life expectancy \< 2 years as determined by the study team

Locations (1)

University of Kansas Medical Center

Kansas City, Kansas, United States

Key Dates

Start Date

October 20, 2020

Primary Completion Date

July 2, 2021

Completion Date

July 2, 2021

Last Updated

July 9, 2021

Enrollment

ACTUAL participants

Conditions

HypertensionCognitive Decline

Interventions

Virtual Collaborative Care Clinic

OTHER

Natural History of Noncirrhotic Portal Hypertension

NCT02417740

Cystic FibrosisImmunologic Deficiency Syndrome+3 more

View study

RECRUITINGPHASE2

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820

Pulmonary Hypertension

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 9, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Remote Monitoring and Virtual Collaborative Care For Hypertension Control To Prevent Cognitive Decline

Inclusion Criteria

Exclusion Criteria

Natural History of Noncirrhotic Portal Hypertension

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

Lombard Cohort of Brain Health Services

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Penn Medicine Healthy Heart